Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Five-Year EU Benefit-Risk Project Bearing Fruit, Says EMA

This article was originally published in SRA

Executive Summary

In what can be seen as an example of the benefits of EU-wide research projects in the life science area, the European Medicines Agency says that the public-private PROTECT project, which ran for five years from late 2009 to early 2015, is already making a difference in the way that companies and regulators measure the benefits and risks of marketed medicines1.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst